CSIC Research Professor and Scientific Director of CIBER-BBN and the Custom Antibody Service (CAbS), a facility of the ICTS NANBIOSIS. As head of the Nanobiotechnology for Diagnostics (Nb4D) group, she coordinates a multidisciplinary research team whose scientific activity is focused on developing a new generation of diagnostic approaches based on the integration of custom-designed bioreceptors with innovative micro(nano)structures and/or optical or electrochemical transducers. Her scientific activity is guided by the vision of a future where diagnostics are based on personalized molecular fingerprints, which poses significant technological challenges. She is currently interested in developing innovative diagnostic approaches for infectious diseases with an original perspective in which cellular communication becomes the primary focus.

She has co-authored nearly 250 scientific articles, registered 15 patents—some of which are licensed—and has several active exploitation contracts. Most of her research is conducted within the context of international collaborations with renowned research institutions, companies, and other stakeholders.